BATTISTA, THEO
BATTISTA, THEO
Optimization of Potent and Specific Trypanothione Reductase Inhibitors: A Structure-Based Drug Discovery Approach
2022 Battista, T; Federico, S; Brogi, S; Pozzetti, L; Khan, T; Butini, S; Ramunno, A; Fiorentino, E; Orsini, S; Di Muccio, T; Fiorillo, A; Exertier, C; Di Risola, D; Colotti, G; Gemma, S; Ilari, A; Campiani, G
Profiling calcium-dependent interactions between Sorcin and intrinsically disordered regions of human proteome
2020 Genovese, Ilaria; Carotti, Andrea; Ilari, Andrea; Fiorillo, Annarita; Battista, Theo; Colotti, Gianni; Ivarsson, Ylva
Roles of sorcin in drug resistance in cancer: One protein, many mechanisms, for a novel potential anticancer drug target
2020 Battista T.; Fiorillo A.; Chiarini V.; Genovese I.; Ilari A.; Colotti G.
Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases
2020 Genovese, I; Giamogante, F; Barazzuol, L; Battista, T; Fiorillo, A; Vicario, M; D'Alessandro, G; Cipriani, R; Limatola, C; Rossi, D; Sorrentino, V; Poser, E; Mosca, L; Squitieri, F; Perluigi, M; Arena, A; van Petegem, F; Tito, C; Fazi, F; Giorgi, C; Cali, T; Ilari, A; Colotti, G
Targeting trypanothione reductase, a key enzyme in the redox trypanosomatid metabolism, to develop new drugs against leishmaniasis and trypanosomiases
2020 Battista T.; Colotti G.; Ilari A.; Fiorillo A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Optimization of Potent and Specific Trypanothione Reductase Inhibitors: A Structure-Based Drug Discovery Approach | 1-gen-2022 | Battista, T; Federico, S; Brogi, S; Pozzetti, L; Khan, T; Butini, S; Ramunno, A; Fiorentino, E; Orsini, S; Di Muccio, T; Fiorillo, A; Exertier, C; Di Risola, D; Colotti, G; Gemma, S; Ilari, A; Campiani, G | |
| Profiling calcium-dependent interactions between Sorcin and intrinsically disordered regions of human proteome | 1-gen-2020 | Genovese, Ilaria; Carotti, Andrea; Ilari, Andrea; Fiorillo, Annarita; Battista, Theo; Colotti, Gianni; Ivarsson, Ylva | |
| Roles of sorcin in drug resistance in cancer: One protein, many mechanisms, for a novel potential anticancer drug target | 1-gen-2020 | Battista T.; Fiorillo A.; Chiarini V.; Genovese I.; Ilari A.; Colotti G. | |
| Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases | 1-gen-2020 | Genovese, I; Giamogante, F; Barazzuol, L; Battista, T; Fiorillo, A; Vicario, M; D'Alessandro, G; Cipriani, R; Limatola, C; Rossi, D; Sorrentino, V; Poser, E; Mosca, L; Squitieri, F; Perluigi, M; Arena, A; van Petegem, F; Tito, C; Fazi, F; Giorgi, C; Cali, T; Ilari, A; Colotti, G | |
| Targeting trypanothione reductase, a key enzyme in the redox trypanosomatid metabolism, to develop new drugs against leishmaniasis and trypanosomiases | 1-gen-2020 | Battista T.; Colotti G.; Ilari A.; Fiorillo A. |